AzTrials
AzTrials

Lifestyle InterventionNCT04567121

Internet Technology Based Life-style and Care Intervention for Risk Factors of Non Communicable Diseases(NCD)

A study testing Intensive intervention group and standard intervention group in people with Lifestyle Intervention and Non Communicable Diseases, run by Beijing Tsinghua Chang Gung Hospital at 1 site in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to control risk factors of non communicable diseases by life style and care intervention based on internet technology, looking forward to improve cardiovascular and cerebrovascular complications, diabetes and all-cause death. Read more about this study

Who is it for?
Ages 25 years and olderHealthy volunteers can take part
What is being tested?
Intensive intervention group and standard intervention group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60,000 participants
Where
1 siteChina
Study dates
1 Jan 2018to 1 Dec 2070
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Men and women older than 25 years of age with two or more risk factors as follows, BMI≥24 or BMI≤18.5 kg/m2, smoking, active exercise less than 30 minutes every day, blood pressure higher than 130/85 mmHg, dyslipidemia, fasting glucose higher than 6.1mmol/l, fatty liver.
  • Patients with hypertension, diabetes and ASCVD

Who cannot join

  • Patients had not signed the consent form
  • Patients with severe heart failure, hepatic failure, renal failure and malignant tumor.
  • Patients planing pregnancy

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

jianzhong xiao, PHD contact

+8613683685711

xiaojzh858@sina.com

China1 site, 1 recruiting
  • Beijing Tsinghua Changgung Hospital

    Beijing, Beijing Municipality, Beijing, BJ 10

    zhaoxiang liu, MD, +8613718898419, lzxa01684@btch.edu.cn

    Recruiting

Other trials in China

About this study

Official title: Internet Technology Based Life-style and Care Intervention for Risk Factors of Non Communicable Diseases(NCD)-a Randomized, Controlled Trial in Communities Following Up for 50 Years

This study aims to control risk factors of non communicable diseases by life style and care intervention based on internet technology, looking forward to improve cardiovascular and cerebrovascular complications, diabetes and all-cause death.

Read the detailed description

Cardiovascular and cerebrovascular diseases, diabetes, chronic obstructive pulmonary disease and malignant tumors are the main chronic diseases, which have been the most important cause of human death, consuming most health resources. In China, patients with cardiovascular and cerebrovascular diseases account for more than 40% of all causes of death. After half a century of research, we have a thorough understanding of risk factors of cardiovascular disease, including genetics, aging, ethnicity, physical activity decreases, unbalanced nutrition and calorie intake, smoking, obesity, hypertension, dyslipidemia, and glucose abnormalities, etc. Many factors can be corrected through health education, indicating that the occurrence of chronic diseases can be prevented through lifestyle changes and the control of risk factors.

This project collects risk factors of cardiovascular disease and establishes a real and reliable health database by conducting a cross-sectional survey of chronic diseases among residents of Tian Tong Yuan District (there are hundreds of thousands of people).On this basis, community health management network was established with internet technology. Meanwhile, prospective, open, community randomized and controlled lifestyle intervention studies were carried out. Intervention was conducted on risk factors of cardiovascular and cerebrovascular diseases, such as smoking, obesity, hypertension, lipid metabolism disorder, and hyperglycemia. For patients with chronic diseases, lifestyle intervention and health education should be carried out to improve the diagnosis rate and control rate. The project focuses on the impact of lifestyle interventions and health education on risk factor control, cardiovascular and cerebrovascular complications, diabetes and all-cause death.

Being tested
Intensive intervention group, standard intervention group
Keywords
Internet Technology, lifestyle intervention, Non Communicable Diseases
Medical subject headings
Noncommunicable Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intensive intervention groupBehavioural

    Establish a team of chronic disease prevention managers (5 people), with each educator responsible for the intervention of 200 people. For sub-health population and chronic disease patients, there would be conducted health education interview twice, 4 calls, online communication 50 times once a year, controlling risk factors and making treatment plan.

  • standard intervention groupBehavioural

    Conduct general health education without active management

Study groups in NCT04567121
Study groupRoleWhat they receive
Intensive intervention groupOtherintensive life-style and care intervention
Receives: Behavioral: Intensive intervention group
Standard intervention groupOtherstandard life-style and care intervention
Receives: Behavioral: standard intervention group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. incidence rate of new noncommunicable diseases

    incidence rate of new noncommunicable diseases, for example, ASCVD, diabetes mellitus, hypertension

    Measured: 2 year

  2. incidence rate of major adverse cardiovascular events

    incidence rate of major adverse cardiovascular events, including nonfatal stroke, nonfatal myocardial infarction, and cardiovascular death

    Measured: 2 years

  3. incidence rate of all-cause mortality

    incidence rate of all-cause mortality in the population

    Measured: 2 years

Secondary outcomes (2)
  1. score of quality of life (SF-36 scale)

    the improvement of quality of life

    Measured: 2 years

  2. Reduce the economic burden on health

    survey of health economic burden, calculate medical expenses

    Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Sep 2020
  2. Study start1 Jan 2018
  3. Primary completion1 Jan 2070 (estimated)
  4. Study completion1 Dec 2070 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04567121
Sponsor's protocol ID
20281-0-01
Status last verified
May 2024
First submitted
7 Sep 2020
Last updated
11 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Intensive intervention group and standard intervention group in people with Lifestyle Intervention and Non Communicable Diseases, run by Beijing Tsinghua Chang Gung Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 11 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact jianzhong xiao, PHD (+8613683685711, xiaojzh858@sina.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

incidence rate of new noncommunicable diseases (time frame: 2 year). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Feb 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in